SLC5A2 and type 2 diabetes mellitus: Regarding hypoglycemics, biguanides were the most commonly prescribed at admission, followed by SGLT-2 inhibitors and GLP-1 receptor agonists, in accordance with ADA guidelines for T2DM management [20].